<DOC>
	<DOCNO>NCT02734355</DOCNO>
	<brief_summary>The objective study estimate efficacy telmisartan amlodipine combination restoration leave atrial mechanical function atrial fibrillation catheter ablation .</brief_summary>
	<brief_title>Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation</brief_title>
	<detailed_description>64 candidate atrial fibrillation ablation include study . Patients randomly assign telmisartan/amlodipine combination dose 80/5 mg ( group I , n=34 ) placebo ( group II , n=30 ) take daily one week . Echocardiography perform procedure , immediately , week therapy . The six-minute walk test SF-36 questionnaire result evaluate day procedure week therapy . The left ventricular end-diastolic pressure invasively measure transseptal puncture leave atrial sheath removal .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Symptomatic ( IIIIV class European Heart Rhythm Association scale ) paroxysmal atrial fibrillation ; Ineffective therapy least one class I III antiarrhythmic drug ; Left atrial diameter 5 cm less ; Estimated catheter radiofrequency pulmonary vein antrum isolation ; Signed informed consent . Intolerance/allergy contraindication telmisartan , amlodipine , warfarin enoxaparin ; Left atrial thrombosis ; Age great 75 year ; Severe ( e.g . decompensation vital function ) acute ( e.g . pneumonia ) somatic condition ; Malignant growth hematogenic dissemination stage .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>catheter ablation</keyword>
	<keyword>left atrium</keyword>
	<keyword>mechanical function</keyword>
	<keyword>contractility</keyword>
</DOC>